Francisco Alberto Verdín-Betancourt
Francisco Alberto Verdín-Betancourt has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aurora Elizabeth Rojas-García
Universidad Autónoma de Nayarit
3 shared publications - Briscia Socorro Barrón-Vivanco
Laboratorio de Contaminación y Toxicología Ambiental, Secretaría de Investigación y Posgrado, Universidad Autónoma de Nayarit, Tepic, Mexico
2 shared publications - Cyndia Azucena González-Arias
Laboratorio de Contaminación y Toxicología Ambiental, Secretaría de Investigación y Posgrado, Universidad Autónoma de Nayarit, Tepic, Mexico
2 shared publications - Irma Martha Medina-Díaz
Laboratorio de Contaminación y Toxicología Ambiental, Secretaría de Investigación y Posgrado, Universidad Autónoma de Nayarit, Tepic, Mexico
2 shared publications - José Francisco Herrera-Moreno
Laboratorio de Contaminación y Toxicología Ambiental, Secretaría de Investigación y Posgrado, Universidad Autónoma de Nayarit, Tepic, Mexico
2 shared publications - Néstor Ponce-Ruíz
Unidad Especializada de Ciencias Ambientales, CENITT, Av. Emilio M. González S/N. Ciudad del Conocimiento, Tepic, Nayarit, México
2 shared publications
Latest Publications
- 19 August 2026
- Published by Springer Nature in Archives of Environmental Contamination and Toxicology
- Vol. 91 (2) , 14
Occurrence and Spatial Distribution of Pesticide Residues in Tropical Agricultural Soils of Northwestern Mexico
- 19 August 2026
- Published by Springer Nature in Archives of Environmental Contamination and Toxicology
- Vol. 91 (2) , 14
Occurrence and Spatial Distribution of Pesticide Residues in Tropical Agricultural Soils of Northwestern Mexico
- 24 March 2026
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 99 (3)
Dialkylphosphate urinary metabolites and cholinesterase activities in Mexican indigenous farmworkers
Organophosphate (OP) pesticides are widely used in agriculture, vector control, and represent a global public health concern, particularly for occupationally exposed farmers and applicators. This study aimed to evaluate the associations among urinary dialkylphosphate (DAP) metabolites, cholinesterase activities, and butyrylcholinesterase (BuChE) polymorphisms in an indigenous population in Mexico. A cross-sectional study was conducted among 191 farmworkers. Data were collected using a structured questionnaire addressing sociodemographic characteristics, lifestyle factors, pesticide exposure, and dietary intake. Venous blood and urine samples were obtained to determine cholinesterase activities and urinary DAP concentrations, respectively. Detectable urinary DAP levels were identified, with dimethylthiophosphate (DMTP) as the predominant metabolite. BuChE activity was significantly associated with dietary lipid and carbohydrate intake. A high prevalence of ancestral genotypes was observed in the BuChE gene. Age-stratified analyses demonstrated differences in cholinesterase activities, and males with low BuChE activity exhibited higher urinary DAP metabolite concentrations. These findings highlight variability in OP pesticide metabolite levels and their relationships with dietary factors and genetic background among indigenous agricultural workers. Improved understanding of these interactions is essential for mitigating exposure-related health risks in vulnerable populations.
- 24 March 2026
- Published by Springer Nature in International Archives of Occupational and Environmental Health
- Vol. 99 (3)
Dialkylphosphate urinary metabolites and cholinesterase activities in Mexican indigenous farmworkers
Organophosphate (OP) pesticides are widely used in agriculture, vector control, and represent a global public health concern, particularly for occupationally exposed farmers and applicators. This study aimed to evaluate the associations among urinary dialkylphosphate (DAP) metabolites, cholinesterase activities, and butyrylcholinesterase (BuChE) polymorphisms in an indigenous population in Mexico. A cross-sectional study was conducted among 191 farmworkers. Data were collected using a structured questionnaire addressing sociodemographic characteristics, lifestyle factors, pesticide exposure, and dietary intake. Venous blood and urine samples were obtained to determine cholinesterase activities and urinary DAP concentrations, respectively. Detectable urinary DAP levels were identified, with dimethylthiophosphate (DMTP) as the predominant metabolite. BuChE activity was significantly associated with dietary lipid and carbohydrate intake. A high prevalence of ancestral genotypes was observed in the BuChE gene. Age-stratified analyses demonstrated differences in cholinesterase activities, and males with low BuChE activity exhibited higher urinary DAP metabolite concentrations. These findings highlight variability in OP pesticide metabolite levels and their relationships with dietary factors and genetic background among indigenous agricultural workers. Improved understanding of these interactions is essential for mitigating exposure-related health risks in vulnerable populations.
- 7 February 2022
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 52 (2) , 113-124
Temephos, an organophosphate larvicide for residential use: a review of its toxicity
Temephos (O,O,O',O′-tetramethyl O,O′-thiodi-p-phenylene bis(phosphorothioate)) is a larvicide belonging to the family of organophosphate pesticides used for the control of different vectors of diseases, such as dengue, Zika, chikungunya, and dracunculiasis. The aim of this review was to discuss the available published information about temephos toxicokinetics and toxicity in mammals. Temephos is quickly absorbed in the gastrointestinal tract, distributed to all organs, and then it accumulates mainly in adipose tissue. It is metabolized by S-oxidation, oxidative desulfuration, and hydrolysis reactions, with the possible participation of cytochrome P450 (CYP). Temephos is mainly eliminated by feces, whereas some of its metabolites are eliminated by urine. The World Health Organization classifies it as class III: slightly dangerous with a NOAEL (no-observed adverse effect level) of 2.3 mg/kg/day for up to 90 days in rats, based on brain acetylcholinesterase (AChE) inhibition. A LOAEL (lowest observable adverse effect level) of 100 mg/kg/day for up to 44 days in rats was proposed based on cholinergic symptoms. However, some studies have shown that temephos causes toxic effects in mammals. The inhibition of the enzyme acetylcholinesterase (AChE) is one of its main demonstrated effects; however, this larvicide has also shown genotoxic effects and some adverse effects on male reproduction and fertility, as well as liver damage, even at low doses. We performed an extensive review through several databases of the literature about temephos toxicokinetics, and we recommend to revisit current assessment of temephos with the new available data.
- 7 February 2022
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 52 (2) , 113-124
Temephos, an organophosphate larvicide for residential use: a review of its toxicity
Temephos (O,O,O',O′-tetramethyl O,O′-thiodi-p-phenylene bis(phosphorothioate)) is a larvicide belonging to the family of organophosphate pesticides used for the control of different vectors of diseases, such as dengue, Zika, chikungunya, and dracunculiasis. The aim of this review was to discuss the available published information about temephos toxicokinetics and toxicity in mammals. Temephos is quickly absorbed in the gastrointestinal tract, distributed to all organs, and then it accumulates mainly in adipose tissue. It is metabolized by S-oxidation, oxidative desulfuration, and hydrolysis reactions, with the possible participation of cytochrome P450 (CYP). Temephos is mainly eliminated by feces, whereas some of its metabolites are eliminated by urine. The World Health Organization classifies it as class III: slightly dangerous with a NOAEL (no-observed adverse effect level) of 2.3 mg/kg/day for up to 90 days in rats, based on brain acetylcholinesterase (AChE) inhibition. A LOAEL (lowest observable adverse effect level) of 100 mg/kg/day for up to 44 days in rats was proposed based on cholinergic symptoms. However, some studies have shown that temephos causes toxic effects in mammals. The inhibition of the enzyme acetylcholinesterase (AChE) is one of its main demonstrated effects; however, this larvicide has also shown genotoxic effects and some adverse effects on male reproduction and fertility, as well as liver damage, even at low doses. We performed an extensive review through several databases of the literature about temephos toxicokinetics, and we recommend to revisit current assessment of temephos with the new available data.